CFO of Karuna Therapeutics Inc (30-Year Financial, Insider Trades) Troy A. Ignelzi (insider trades) sold 8,000 shares of KRTX on 06/16/2020 at an average price of $92.31 a share. The total sale was $738,480.
Karuna Therapeutics Inc has a market cap of $2.56 billion; its shares were traded at around $97.93 . GuruFocus has detected 1 severe warning sign with Karuna Therapeutics Inc. .
CFO Recent Trades:
- CFO Troy A. Ignelzi sold 8,000 shares of KRTX stock on 06/16/2020 at the average price of $92.31. The price of the stock has increased by 6.09% since.
Directors and Officers Recent Trades:
- COO Andrew Craig Miller sold 25,000 shares of KRTX stock on 06/16/2020 at the average price of $94.41. The price of the stock has increased by 3.73% since.
- Director Edmund Harrigan sold 30,000 shares of KRTX stock on 06/12/2020 at the average price of $91.79. The price of the stock has increased by 6.69% since.
- Director Atul Pande sold 5,000 shares of KRTX stock on 06/12/2020 at the average price of $93.27. The price of the stock has increased by 5% since.
- Chief Medical Officer Stephen K. Brannan sold 7,728 shares of KRTX stock on 06/01/2020 at the average price of $90.64. The price of the stock has increased by 8.04% since.
- COO Andrew Craig Miller sold 25,000 shares of KRTX stock on 06/01/2020 at the average price of $90.64. The price of the stock has increased by 8.04% since.
For the complete insider trading history of KRTX, click here
.
